Tailor Made Compounding

FDA Regulatory Profile

Tailor Made Compounding appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0223-2019, Class II) was initiated on September 28, 2018.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0223-2019Class IITesamorelin, 1mg/vial, 6mL vial, Lyophilized Powder for Reconstitution and Subcutaneous Injection, RSeptember 28, 2018